ADO Antikörper (AA 49-261) (Fluoro594)
Kurzübersicht für ADO Antikörper (AA 49-261) (Fluoro594) (ABIN7964783)
Target
Alle ADO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 49-261
-
Verwendungszweck
- Anti-ADO Antibody Fluoro594 Conjugated
-
Spezifität
- No cross reactivity with other proteins.
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Homologie
- coli-derived human ADO recombinant protein (Position: E49-E261). Human ADO shares 90.1% amino acid (aa) sequence identity with mouse ADO.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human ADO recombinant protein (Position: E49-E261). Human ADO shares 90.1% amino acid (aa) sequence identity with mouse ADO.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))
-
Andere Bezeichnung
- ADO
-
Hintergrund
-
Background: Human thiol dioxygenases include cysteine dioxygenase (CDO) and cysteamine (2-aminoethanethiol) dioxygenase (ADO). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine. It is demonstrated that mouse Ado has strong and specific dioxygenase activity in vitro towards cysteamine but not cysteine. Recombinant Ado was shown to bind iron. Overexpression of Ado in HepG2/C3A cells increased the production of hypotaurine from cysteamine. Similar results were found with human ADO. When endogenous expression of ADO was reduced by RNA-mediated interference, hypotaurine production decreased. It is also noted that the demonstration of high levels of ADO in brain challenges the previous assumption that most of the taurine in the brain is a consequence of CDO activity.
Gene Full Name: 2-aminoethanethiol dioxygenase
-
UniProt
- Q96SZ5
Target
-